Literature DB >> 2802022

Association of the virus-like infectious agent originally reported in patients with AIDS with acute fatal disease in previously healthy non-AIDS patients.

S C Lo1, M S Dawson, P B Newton, M A Sonoda, J W Shih, W F Engler, R Y Wang, D J Wear.   

Abstract

We studied 6 patients from 6 different geographic areas who presented with acute flu-like illnesses. The patients developed persistent fevers, lymphadenopathy or diarrhea, pneumonia, and/or heart, liver, or adrenal failure. They died in 1-7 weeks. These patients had no serological evidence of HIV infection and could not be classified as AIDS patients according to CDC criteria. The clinical signs as well as laboratory and pathological studies of these patients suggested an active infectious process, although no etiological agent was found despite extensive infectious disease work-ups during their hospitalization. Post-mortem examinations showed histopathological lesions of fulminant necrosis involving the lymph nodes, spleen, lungs, liver, adrenal glands, heart, and/or brain. No viral inclusion cells, bacteria, fungi, or parasites could be identified in these tissues using special tissue stains. We report that immunohistochemistry using rabbit antiserum raised against VLIA, the virus-like infectious agent previously identified in patients with AIDS and shown to cause fatal systemic infection in primates, revealed VLIA antigens in these necrotizing lesions. In situ hybridization using an 35S labeled VLIA-specific DNA probe also detected VLIA genetic material in the areas of necrosis. Furthermore, virus-like particles closely resembling VLIA were identified ultrastructurally in these histopathological lesions. VLIA was associated with the systemic necrotizing lesions in these previously healthy non-AIDS patients with an acute fatal disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2802022

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

1.  Localized frameshift mutation generates selective, high-frequency phase variation of a surface lipoprotein encoded by a mycoplasma ABC transporter operon.

Authors:  P Theiss; K S Wise
Journal:  J Bacteriol       Date:  1997-06       Impact factor: 3.490

2.  Pathogenicity of Mycoplasma fermentans and Mycoplasma penetrans in experimentally infected chicken embryos.

Authors:  M M Hayes; B J Li; D J Wear; S C Lo
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

3.  Genotypic and phenotypic analysis of Mycoplasma fermentans strains isolated from different host tissues.

Authors:  L Campo; P Larocque; T La Malfa; W D Blackburn; H L Watson
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

4.  Mycoplasma penetrans and other mycoplasmas in urine of human immunodeficiency virus-positive children.

Authors:  A I Hussain; W L Robson; R Kelley; T Reid; J D Gangemi
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

5.  Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease.

Authors:  C B Faulkner; J W Simecka; M K Davidson; J K Davis; T R Schoeb; J R Lindsey; M P Everson
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

6.  Differential protein expression and surface presentation generate high-frequency antigenic variation in Mycoplasma fermentans.

Authors:  P M Theiss; M F Kim; K S Wise
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

8.  Evidence that Lo's mycoplasma (Mycoplasma fermentans incognitus) is not a unique strain among Mycoplasma fermentans strains.

Authors:  T Sasaki; Y Sasaki; M Kita; K Suzuki; H Watanabe; M Honda
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

9.  Role of mycoplasma infection in the cytopathic effect induced by human immunodeficiency virus type 1 in infected cell lines.

Authors:  M Lemaître; Y Henin; F Destouesse; C Ferrieux; L Montagnier; A Blanchard
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

10.  Protein and antigen heterogeneity among strains of Mycoplasma fermentans.

Authors:  C T Städtlander; C Zuhua; H L Watson; G H Cassell
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.